GLP-1 medication (Tirzepatide / Mounjaro & Semaglutide / Ozempic / Rybelsus / Wegovy)

Currently, GPs are only able to prescribe GLP-1 agonist medication for patients with diabetes who meet certain criteria. Some patients may be eligible for the medication to aid weight loss via an NHS referral to local weight management services.

These medications are being accessed by some people via private providers. It is important to consider the following if you are considering starting a GLP-1 medication.

You should only take GLP-1 medicines if they have been prescribed to you by a healthcare professional.

Always have a conversation with your prescriber about the benefits and risks of GLP-1 medicines before you start taking them and make sure they are aware of your medical conditions and any medications you are already taking.

Do not take GLP-1 medicines if you are pregnant, trying to get pregnant or breastfeeding. If you get pregnant while using them, talk to a healthcare professional straight away.

If you are prescribed Tirzepatide (Mounjaro), and you are using an oral contraceptive (the pill), use a non-oral form (such as condoms, the coil/IUD, implant, depot injection or patch) of contraception in addition to your pill for four weeks after starting GLP-1 medicines and for 4 weeks after any increase in dose.

Tirzepatide (Mounjaro) & Semaglutide (Wegovy/Rybelsus/Ozempic) may have an impact on the effectiveness of your HRT to adequately protect your endometrium (womb lining). Please do contact your GP for a review so they can discuss potential alternatives.

Understand the potential side effects and have a conversation with a healthcare professional if you are concerned.

Tell your doctor you take a GLP-1 medicine if you are about to have surgery.

Report any adverse reactions to the yellow card scheme: Yellow Card | Making medicines and medical devices safer

For more information, please see this link: GLP-1 medicines for weight loss and diabetes: what you need to know – GOV.UK.